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Localization of memory CD8þ T cells to lymphoid or peripheral tissues is believed to
correlate with proliferative capacity or effector function. Here we demonstrate that the
fractalkine-receptor/CX3CR1 distinguishes memory CD8
þ T cells with cytotoxic effector
function from those with proliferative capacity, independent of tissue-homing properties.
CX3CR1-based transcriptome and proteome-profiling defines a core signature of memory
CD8þ T cells with effector function. We find CD62LhiCX3CR1þ memory T cells that reside
within lymph nodes. This population shows distinct migration patterns and positioning in
proximity to pathogen entry sites. Virus-specific CX3CR1
þ memory CD8þ Tcells are scarce
during chronic infection in humans and mice but increase when infection is controlled
spontaneously or by therapeutic intervention. This CX3CR1-based functional classification will
help to resolve the principles of protective CD8þ T-cell memory.
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U
pon challenge with infectious intracellular microorgan-
isms such as viruses and intracellular bacteria, the
immune systems mounts a rapid and commensurate
response characterized by an early innate inflammatory response
that is followed by generation of pathogen-specific CD8þ T-cell
immunity. Such CD8þ T-cell immunity is important to eliminate
or at least contain infection with intracellular pathogens1,2. Memory
CD8þ T cells generated in response to the initial pathogen
encounter survive in the absence of further antigen-specific
stimulation3 but also survive during chronic infection and
continuous antigen challenge4. Memory CD8þ T cells provide
protection against re-infection with the same pathogen but may also
contribute to long-term control of infection if the pathogen cannot
be completely eliminated, such as during infection with herpes
viruses or hepatitis viruses. Initially, two discrete memory CD8þ
T-cell populations were characterized by their distinct tissue
localization that are believed to be linked to their functionality:
central memory T cells (TCM) with proliferative potential that
localize to lymphoid tissues and effector memory T cells (TEM) with
direct cytotoxic effector functions that reside in peripheral tissues5.
Consequently, TCM were distinguished from TEM by differential
expression of the lymphoid-tissue homing receptors CD62L and
CCR7 (ref. 5). Proliferation of memory T cells is required to
generate sufficient numbers of effector T cells to control infection,
whereas memory T cells with direct cytotoxic effector function are
important to provide immediate protection in infected tissues6.
However, this strict correlation between memory CD8þ T-cell
function and their localization was challenged by the finding that
T cells with effector functions in the memory T-cell population
directly mediate protective immunity6 and the discovery of tissue-
resident memory T cells (TRM) that possess effector function and
have the capacity for self-renewal yet do not recirculate to lymphoid
tissues7. Furthermore, invasion of lymphoid tissues by bacteria and
viruses indicated the necessity of T cells with effector function to be
present in lymphoid tissues8, which cannot be explained by our
current understanding. Rather than looking at bulk T-cell
populations that localize to particular tissues, more sophisticated
distinction via surface markers is necessary to better understand the
mechanisms determining T-cell immunity. Attempts have been
made to establish phenotypic markers that predict the functional
properties of memory T cells6,9. Although distinct memory T-cell
populations that differ in their functional, proliferative and
trafficking characteristics have been recognized10,11, it has not
been investigated whether functionally distinct memory T-cell
populations exist among CD62Lþ TCM in lymph nodes.
Here we report that the expression of the fractalkine receptor
CX3CR1 discriminates memory CD8þ T cells with cytotoxic
effector function from those with proliferative potential both in
humans and mice. Using CX3CR1 together with CD62L as
markers, we determine a core gene and protein signature of
memory CD8þ T cells with cytotoxic effector functions. This
allowed us to identify a CX3CR1þCD62Lhi memory T-cell
population with direct effector function. This population is
stationary in the lymph node and locates to the subcapsular area
where pathogens enter. We find low numbers of CX3CR1þ
memory CD8þ T cells with effector function in patients suffering
from chronic viral infection and high numbers in patients who
recovered from viral infection. Also in preclinical models of chronic
viral infection, that is, lymphocytic choriomeningitis virus (LCMV)
clone 13 infection, numbers of CX3CR1þ memory CD8þ T cells
correlate with control of infection and response to immune therapy.
Results
CX3CR1 expression on memory CD8þ T cells. We have
previously reported a unique murine memory CD8þ T-cell
population with proliferative potential that is distinct from
TCM and is induced by non-professional antigen-presenting cells
in the liver but not lymphoid tissues12. We reassessed our
previously published set of whole-genome transcriptome data
utilizing an analysis of variance (ANOVA) model to detect
differentially expressed genes as well as self-organizing-map
analysis of gene expression profiles to identify genes specific for
memory T cells12. We found the fractalkine receptor CX3CR1
among genes coding for cell surface receptors that were most
upregulated within a memory-specific cluster of genes (Fig. 1a
and Supplementary Fig. 1A). CX3CR1 has been reported to define
subsets of myeloid cells, including monocytes and dendritic cells,
in the blood and different tissues, such as the gut and lymph
nodes13–15. So far, CX3CR1 expression on a protein level was
detected on CD4þ T cells residing in the lung or skin16,17.
However, to date, this was not analysed in detail for memory
CD8þ T cells, although published transcriptome analysis in
memory CD8þ T cells indicated the expression of the Cx3cr1
gene18,19 and CX3CR1 was detected on terminally differentiated
cytotoxic effector T cells20. To analyse the expression pattern
of CX3CR1 in CD8þ T cells during the course of infection
and memory formation, we used CX3CR1þ /GFP reporter mice13,
in which GFP expression correlated with CX3CR1 protein
expression (Supplementary Fig. 1B).
In healthy mice, we observed GFP (CX3CR1) expression on
some antigen-experienced CD44þ but not naive CD44low CD8þ
T cells (Fig. 1b). The frequency of CX3CR1-expressing
T cells among total CD8þ T cells increased after adenoviral
infection (d60) (Fig. 1b,c). Among CD44þ T cells, CX3CR1
expression was most prominent in CD8þ T cells (Fig. 1d),
prompting us to study CX3CR1 expression on antigen-specific
memory CD8þ T cells in response to infection. After infection
with a recombinant adenovirus coding for luciferase and
ovalbumin (OVA), which results in hepatocyte infection that
can be monitored by in vivo bioluminescence measurement21,
in vivo activation of ovalbumin-specific OT-ICX3CR1-GFP T cells
was observed at 2 days post infection (d.p.i.) as demonstrated by
increased CD44 expression. GFP (CX3CR1) expression, however,
was not detected before 5 d.p.i. when control over viral infection
had been achieved (Fig. 1e), as determined by reduction of in vivo
bioluminescence (Fig. 1f). The total numbers of GFPþ
(CX3CR1þ ) T cells were highest at 5 d.p.i. and then gradually
decreased parallel to the total numbers of antigen-specific CD8þ
T cells (Supplementary Fig. 1C) consistent with contraction.
Antigen-specific GFPþ (CX3CR1þ ) and GFPneg (CX3CR1neg)
CD8þ T cells were found in the lymphoid tissue like in the
spleen but also in the blood and liver after viral infection
(Supplementary Fig. 1D). The GFP (CX3CR1) expression level
per CD8þ T cell increased during this time by one log (Fig. 1e
and Supplementary Fig. 1E). These findings were corroborated
studying CX3CR1 expression on antigen-specific CD8þ T cells
generated from the endogenous T-cell repertoire. CX3CR1þ
expression was observed after infection with adenovirus
(AdOVA) or Listeria monocytogenes (L.m.-OVA) on
OVA-specific memory CD8þ T cells and after LCMV infection
on LCMV-gp33-specific memory CD8þ T cells (Supplementary
Fig. 1F). At 60 d.p.i. of CX3CR1þ /GFP reporter mice, the majority
of CD8þ T cells in the blood and spleen, which were specific for
OVA (after AdOVA or L.m.-OVA infection) or LCMV-gp33,
showed GFP (CX3CR1) expression (Fig. 1g and Supplementary
Fig. 1G). A similar separation in CX3CR1þ and CX3CR1neg
populations was observed in memory CD8þ T cells generated
from 500 adoptively transferred naive OT-ICX3CR1-GFP CD8þ
T cells (Supplementary Fig. 1H). Even 4200 days after
AdOVA infection, antigen-specific GFPþ (CX3CR1þ ) and
GFPneg (CX3CR1neg) memory CD8þ T cells were found
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Figure 1 | CX3CR1 expression on antigen-experienced memory T cells in mice and man. (a) Quantification of Cx3cr1 mRNA levels on CD44
low naive OT-I
T cells (n¼ 5) and CD44þ memory OT-I T cells (n¼ 3) at 4d45 post L.m.-OVA infection. ***Po0.001, unpaired t-test. (b–d) Frequencies of GFPþ
T cells in untreated or AdOVA i.v infected CX3CR1
þ /GFP reporter mice (n¼ 7) at 60 d.p.i. isolated from the spleen (b,c) and the blood (d). **Po0.01,
unpaired t-test. (e) C57BL/6 mice that had received 3 105 naı¨ve CD44low CD45.1þ OT-ICX3CR1-GFP T cells 1 day before were infected with AdOVALUC
at day 0 and analysed for GFP(CX3CR1)/CD44 expression in OVA-specific CD45.1
þOT-ICX3CR1-GFP T cells at indicated time points. (f) In vivo
bioluminescence activity of mice (n¼ 7) from (e) demonstrating efficient OVA-specific T-cell immunity against virus-infected hepatocytes. C57BL/6 mice
without adoptive T-cell transfer served as control. *Po0.05 and ***Po0.001, two-way ANOVA. (g) CX3CR1þ /GFP mice were infected with AdOVA
(n¼ 10), L.m.-OVA (n¼ 9) or LCMV WE (n¼ 10). Frequencies of GFPþ (CX3CR1þ ) and GFPneg (CX3CR1neg) cells at 45–60 d.p.i. among splenic OVA-
specific CD44þCD8þ Tcells (AdOVA and L.m.-OVA infection) or gp33-specific CD44þ CD8þ Tcells (LCMV infection) identified by Dextramer staining.
(h) Frequencies of GFPþ and GFPneg CD45.1þ cells at4200 days post AdOVA infection of C57BL/6 wild-type mice (n¼ 5) that had received 103 naive
CD45.1þ OT-ICX3CR1-GFP cells before infection. (i) CX3CR1 expression in human CD45ROþ CD3þ T cells isolated from the blood and (j) frequency of
CX3CR1
þ and CX3CR1neg cells among human CD45ROþ CD8þ Tcells (n¼8). In scatter plots, each circle represents one mouse or patient, fluorescence-
activated cell sorting (FACS) plots show representative analysis for one mouse or patient per group. Data are representative for two or three independent
experiments (b,d–f, mean and s.d.) or have been pooled from two independent experiments (c,f–h,j, mean and s.e.m.). In scatter plots, each circle
represents one mouse or a different human donor, FACS plots show representative analysis for one mouse or human donor per group.
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(Fig. 1h) arguing that both memory T-cell populations are long
lived. Importantly, we confirmed CX3CR1 expression on T cells
in healthy human volunteers. Here, CX3CR1 expression was
also most prominent on antigen-experienced CD45ROþ
CD8þ T cells with numbers varying among healthy individuals
(Fig. 1i,j and Supplementary Fig. 1I). Taken together, these data
indicated that CX3CR1 is expressed in a population of murine
and human memory CD8þ T cells.
CX3CR1 expression identifies cytotoxic memory CD8þ T cells.
As GFP (CX3CR1) expression separates memory CD8þ T cells
into two populations (Fig. 1), we addressed the question whether
antigen-specific GFPþ (CX3CR1þ ) and GFPneg (CX3CR1neg)
memory CD8þ T cells generated after viral or bacterial infections
in CX3CR1þ /GFP reporter mice had distinct functional proper-
ties. The ability to produce the cytokine interleukin-2 (IL-2) is
considered a hallmark of those memory T cells that have
the potential to proliferate and generate T-cell progeny22. We
found that GFPneg (CX3CR1neg) memory CD8þ T cells were the
main producers of IL-2 upon re-stimulation, whereas GFPþ
(CX3CR1þ ) memory CD8þ T cells failed to produce significant
amounts of this cytokine (Fig. 2a and Supplementary Fig. 2A). To
directly test the proliferative capacity of GFPþ (CX3CR1þ )
versus GFPneg (CX3CR1neg) memory CD8þ T cells in vivo, we
adoptively transferred both populations and analysed their
numbers after viral or bacterial infections. Transferred GFPneg
(CX3CR1neg) memory CD8þ T cells showed vigorous and
antigen-specific proliferation upon pathogen challenge, whereas
GFPþ (CX3CR1þ ) memory CD8þ T cells showed much less
proliferative capacity (Fig. 2b). Similar results were obtained
using transgenic OT-ICX3CR1-GFP-derived memory CD8þ T cells
after re-challenge with AdOVA infection (Supplementary
Fig. 2B).
Next, we investigated effector functions in GFPþ (CX3CR1þ )
and GFPneg (CX3CR1neg) memory CD8þ T cells. In contrast to
IL-2 expression, only GFPþ (CX3CR1þ ) memory CD8þ T cells
at 60 d.p.i. (L.m.-OVA) constitutively expressed GzmB (Fig. 2c
and Supplementary Fig. 2C), which is a hallmark of T cells with
cytotoxic effector function23. Consequently, only GFPþ
(CX3CR1þ ) OT-ICX3CR1-GFP memory T cells showed potent
cytotoxic effector function directly ex vivo (Fig. 2d). After
adoptive transfer, GFPþ (CX3CR1þ ) OT-ICX3CR1-GFP memory
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Figure 2 | CX3CR1 expression separates memory CD8
þ T cells with distinct functions. (a,b) CX3CR1þ /GFP mice were infected with AdOVA (n¼ 3),
L.m.-OVA (n¼4) or LCMV WE (n¼ 3). At 45–60 d.p.i., spleen-derived GFPþ (CX3CR1þ ) and GFPneg (CX3CR1neg) memory Tcells specific for OVA (after
AdOVA and L.m.-OVA infection) or for LCMV gp33 were obtained by FACSorting. (a) Ex vivo IL-2 production after stimulation with PMA/ionomycin.
***Po0.001, unpaired t-test. (b) Adoptive transfer of sorted OVA-specific or LCMV-specific CD8þ T cells (2 103) into CD90.1þ mice (n¼4)
subsequently infected with AdOVA or LCMV. Determination of CD90.2þ T-cell numbers at 8 d.p.i. in the spleen. *Po0.05 and **Po0.01, unpaired t-test.
(c–e) Adoptive transfer of FACSsorted naive CD45.1þCD44low OT-ICX3CR1-GFP Tcells (5 102) into CD45.2þ mice followed by L.m.-OVA infection. (c) At
45–60 d.p.i, CD45.1þ Memory OT-ICX3CR1-GFP T cells from the spleen were analysed for intracellular GzmB expression (n¼6). **Po0.01, unpaired t-test.
(d) OVA-specific cytotoxicity of sorted GFPþ and GFPneg memory OT-ICX3CR1-GFP T cells directly ex vivo. *Po0.05, ANOVA. (e) Adoptive transfer of
3 105 sorted GFPþ or GFPneg memory OT-ICX3CR1-GFP T cells into mice (n¼ 6) that were infected with AdOVALUC 4h before. In vivo bioluminescence
activity was determined to measure T-cell effector function against virus-infected luciferase-expressing hepatocytes over time. AdOVALUC-infected mice
that did not receive Tcells served as controls (n¼6). Data are representative for —two or three independent experiments. *Po0.05, two-way ANOVA. (f)
Challenge of mice harbouring CD45.1þ Memory OT-ICX3CR1-GFP T cells with AdGFP or AdOVA and 6 h later determination of GzmB expression in splenic
GFPþ and GFPneg memory OT-ICX3CR1-GFP T cells. Data are representative for two independent experiments (a,b,d,e, mean and s.d.) or have been pooled
from two independent experiments (c,f, mean and s.e.m.). In scatter plots of a–c, each dot represents data from one mouse. Fluorescence-activated cell
sorting plots shown in d are representative for one mouse of a group of three or four mice per experiment.
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in vivo protection by rapid control of hepatocyte infection
with AdOVALUC (Fig. 2e). In contrast, GFPneg (CX3CR1neg)
T cells did not control infection (Fig. 2e), which is consistent
with their lack of cytotoxic functions. Upon pathogen
re-challenge, GFPþ (CX3CR1þ ) OT-ICX3CR1-GFP memory T
cells showed further rapid (6 h) increase of GzmB expression.
Interestingly, GzmB expression was also triggered by AdGFP
infection lacking the cognate antigen but was more pronounced
upon AdOVA infection (Fig. 2f), indicating that antigen-specific
restimulation was superior to virus-induced inflammation in
augmenting GzmB expression. Strikingly, GFPneg T cells
remained GzmB negative under such conditions (Fig. 2f),
providing a rationale for the failure of this population to confer
protective immunity upon transfer (Fig. 2e). Interestingly, no
difference in expression of interferon (IFN)-g was observed
between GFPneg and GFPþ T cells (Supplementary Fig. 2D).
Having established the functional segregation of memory CD8þ
T cells based on CX3CR1 expression, we next reconciled our data
with previous work that employed the homing-related molecules
CD62L and CCR7 to separate memory CD8þ T cells into
functionally distinct populations.
CX3CR1 and CD62L identify four memory CD8þ T-cell
populations. Memory T cells have been divided into two
populations based on the expression of CD62L and CCR7 that
allows CD62LhiCCR7þ TCM to localize to lymphoid tissues,
whereas CD62LlowCCR7neg TEM remain in the blood and
peripheral tissues5. Although tissue localization correlates
with expression of these markers, the separation of functional
properties between TCM to generate T-cell progeny and TEM
to show cytotoxic effector functions is less stringent6,24,25.
This led us to analyse GFP (CX3CR1) expression in
CD62LhiCD127þKLRG1neg TCM, CD62LlowCD127þ
KLRG1neg TEM and KLRG1þCD8þ T cells derived from
naı¨ve OT-ICX3CR1-GFP T cells at 60 days after AdOVA infection.
At this time point, all KLRG1þ effector-like CD8þ T cells
showed high GFP (CX3CR1) expression (Fig. 3a). However, 25%
of TEM did not show GFP (CX3CR1) expression (Fig. 3a) and
30% of TCM showed GFP (CX3CR1) expression (Fig. 3a). Based
on this data we reasoned that CX3CR1 in combination with
CD62L might enable a highly specific discrimination of memory
T-cell subsets with distinct functional properties.
Indeed, using CD62L and CX3CR1 in combination, four distinct
populations of memory CD8þ T cells could be discriminated in
mice and healthy humans (Fig. 3b,g). At 60 days after AdOVA
infection in mice, GzmB expression was exclusively found in
GFPþ (CX3CR1þ ) memory OT-ICX3CR1-GFP T cells irrespective
of their CD62L expression level (Fig. 3c). In contrast, IL-2
production after restimulation was restricted to GFPneg
(CX3CR1neg) memory OT-ICX3CR1-GFP T cells, again irrespective
of their CD62L expression levels (Fig. 3d). Along this line, only
GFPneg (CX3CR1neg) CD62Lhi and GFPneg (CX3CR1neg)CD62Llow
memory OT-ICX3CR1-GFP T cells proliferated after adoptive
transfer and AdOVA infection (Fig. 3e). Of note, progeny
CD8þ T cells were comprised of both, GFPþ (CX3CR1þ ) and
GFPneg (CX3CR1neg) T cells (Fig. 3f), indicating that CX3CR1-
expressing CD8þ T cells can arise from GFPneg (CX3CR1neg)
memory CD8þ T cells during recall responses after viral infection.
Also in the polyclonal repertoire of human CD45ROþCD8þ
T cells, staining for CD62L and CX3CR1 identified four
cell populations (Fig. 3g). CCR7 expression was observed in
all CD62Lhi memory T cells and thus did not discriminate
CX3CR1þ from CX3CR1neg memory CD8þ T cells
(Supplementary Fig. 3A). The relative frequencies of these four
populations varied between the 18 healthy individuals studied
(Supplementary Fig. 3B,C). Only CX3CR1þCD62Llow and
CX3CR1þCD62Lhi human memory CD8þ T cells expressed
GzmB (Fig. 3h,i). Accordingly, CD62L expression levels did not
identify GzmB-positive cells among CD45ROþ or CD45RAþ
CD8þ T cells, whereas all GzmB-positive CD8þ T cells stained
positive for CX3CR1 (Supplementary Fig. 3D). Furthermore, IL-2
production following restimulation was only observed in
CX3CR1neg memory CD8þ T cells, although we observed more
prominent IL-2 production in CX3CR1negCD62Lhi compared
with CX3CR1negCD62Llow CD8þ T cells (Fig. 3i). In mice,
several markers, such as CD27, CD28, CD127, and the activation-
associated isoform of CD43 (1B11) have been reported to
correlate with CD8þ T-cell functionality6,9. As the expression
of these markers has not been investigated within CD62Lþ TCM,
especially not in humans, we evaluated their expression in
comparison with our CX3CR1-based separation on human
memory T cells. In human memory T cells, CD43 expression
was rather high in CX3CR1þ CD8þ T cells, whereas CD27
showed higher expression on CX3CR1neg CD8þ T cells
(Supplementary Fig. 3E,F) indicating that the co-regulation of
CD43 and CD27 on human memory CD8þ T cells9,26 does not
allow for clear cut separation with regard to functionality as
CX3CR1-based separation. CD127 expression levels were slightly
higher in CX3CR1neg T cells independent of CD62L expression
levels (Supplementary Fig. 3E,F) consistent with previous reports
on CD127 expression on long-lived central memory T cells27–30.
Also, CD28 expression was slightly increased on CX3CR1neg
T cells (Supplementary Fig. 3E,F) confirming the increased
expression found previously on TCM5,31. Overall, beyond the
resolution achieved by CD62L or other T-cell surface markers,
CX3CR1 expression precisely classifies memory CD8þ
T cells into two distinct populations in mice and humans
independent of their tissue-homing properties, one with cytotoxic
effector function but little proliferative capacity, the other
with proliferative capacity but no cytotoxic function. To
address this notion in an unbiased manner, we decided
to apply transcriptomic and proteomic analyses of human
memory CD8þ T cells.
Core signature of human CX3CR1þ memory CD8þ T cells.
To further understand whether CX3CR1 expression identifies
distinct populations of CD8þ T cells, we performed mRNA-
sequencing of human naive CD62LhiCD45RAþCD8þ T cells,
CX3CR1þCD62Lhi CD45ROþCD8þ T cells, CX3CR1þ
CD62Llow CD45ROþCD8þ T cells, CX3CR1negCD62Lhi
CD45ROþCD8þ T cells and CX3CR1negCD62LlowCD45ROþ
CD8þ T cells, and assessed variable genes by an ANOVA model
(Fig. 4a). Principal component analysis of variable genes within
the data set clearly revealed one distinct population of
CX3CR1þCD8þ T cells irrespective of their CD62L expression
(Fig. 4b). Only in the CX3CR1negCD45ROþCD8þ T cell
populations, CD62L discriminated two separate populations,
albeit they were more closely related to each other than to naı¨ve
CD62Lhi CD45RAþCD8þ T cells and the CX3CR1þ
CD45ROþCD8þ T-cell populations. Hierarchical clustering of
variable genes shown as a heat map (Fig. 4c) confirmed these
findings as naı¨ve CD45RAþCD8þ T cells showed the most
significant difference to the other four CD45ROþ T-cell popu-
lations. CX3CR1negCD62LhiCD8þ T cells and CX3CR1neg
CD62LlowCD8þ T cells had distinct gene expression patterns,
whereas gene expression patterns of CX3CR1þCD62LhiCD8þ T
cells and CX3CR1þCD62LlowCD8þ T cells were almost iden-
tical. Consistent with these results and with the usefulness of
CX3CR1 as marker for functionally distinct T-cell populations, we
found that CX3CR1 expression was similar to CD43 expression,
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whereas other markers for memory T cells, such as CD27, CD28
or CD127, were downregulated in CX3CR1þ CD8þ T cells
independent of their CD62L expression (Supplementary Fig. 3G).
Focusing on differentially expressed genes as determined by the
ANOVA model on present genes directly comparing CD62Lþ
CX3CR1þ CD8þ T cells or CD62L CX3CR1þ CD8þ T cells
to naı¨ve T cells and visualizing the results by ratio/ratio plots,
further confirmed that CX3CR1þCD8þ T cells had almost
identical expression patterns irrespective of CD62L expression
levels (Fig. 4d and Supplementary Data 1). In contrast, CD62Lhi
and CD62Llow CD8þ T cells lacking CX3CR1 showed differential
expression of a subset of genes (Fig. 4e and Supplementary Data
1). To determine a core signature for the CX3CR1þCD45ROþ
CD8þ T cells, we performed an analytical approach combining
the results of the ANOVA model with either co-regulation ana-
lysis or weighted network analysis and subtracted genes also
enriched in CX3CR1 T cells to identify differentially expressed
genes (Fig. 4f). This approach revealed a set of 363 signature
genes (Supplementary Data 2) with high expression in CX3CR1þ
memory T cells, intermediate to low expression in CX3CR1
memory T cells and low to absent expression in naı¨ve CD8þ T
cells (Supplementary Fig. 4). We visualized genes of this CX3CR1-
associated core signature belonging to functional categories
including T-cell cytotoxicity markers, NK-cell markers, T-cell
activation-associated molecules, adhesion molecules and
transcription factors as heat maps of z-transformed expression
values (Fig. 4g). This signature included known cytotoxic
effector molecules such as FAS-L, perforin and GzmA/B/H, or
transcription factors associated with effector function, such as
TBX21, BATF, RUNX3 and EOMES, but also other molecules
whose relation to CD8þ T-cell effector has not been studied yet











































































































































































































































































































































































































































Figure 3 | CX3CR1 and CD62L expression identifies four distinct memory CD8
þ T-cell populations. (a–f) Naive CD45.1þ OT-I CX3CR1-GFP T cells
(5 102) were adoptively transferred into CD45.2 mice subsequently infected with AdOVA. (a) At 60 d.p.i., CX3CR1 expression was determined in
CD45.1þ OT-I-derived KLRG1þ T cells, CD62LlowCD127þCD44þ memory T cells (TEM) and CD62LhiCD127þCD44þ memory T cells (TCM) isolated
from the spleen. (b) Representative analysis of CD62L and GFP (CX3CR1) expression in CD127
þ CD44þ memory OT-ICX3CR1-GFP Tcells from a. (c,d) Four
populations of CD127þ CD44þ memory OT-ICX3CR1-GFP T cells after AdOVA infection separated by CD62L and GFP (CX3CR1) expression levels were
(c) analysed for GzmB expression or (d) sorted and analysed for IL-2 expression after PMA/ionomycine stimulation for 5 h. Unstimulated Tcells from each
population (empty circles) served as control. n¼ 3 or 4 for each group; *Po0.05, **Po0.01, ANOVA. (e,f) Adoptive transfer of identical numbers (2 103
cells) of FACSorted CD45.1þ cells from the four populations of memory Tcells into CD45.2þ mice (n¼4) that were subsequently infected with AdOVA.
(e) At 8 d.p.i., total numbers of CD45.1þ T cells and (f) frequencies of CX3CR1þ cells among CD45.1þ T-cell progeny was determined in the spleen.
*Po0.05, ***Po0.001, ANOVA. (g) Representative analysis showing CD62L and CX3CR1 expression in human CD45ROþCD3þCD8þ PBMCs. (h,i) Flow
cytometric determination of expression of GzmB in the four cell populations stratified by CD62L and CX3CR1 expression. ***Po0.001, ANOVA. (j) IL-2
expression in FACSorted cells from these four T-cell populations subjected to PMA/ionomycine stimulation for 5 h. **Po0.01 and ***Po0.001, ANOVA.
Fluorescence-activated cell sorting (FACS) plots are representative for three (a–c) or five (g,h) independent experiments. Data from one of three
independent experiments are show in c–f each dot represents T cells from one mouse. (i,j) Pooled data for T cells from n¼ 6 individual donors.
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Figure 4 | Transcriptome analysis reveals a core signature of human CX3CR1-expressing memory CD8
þ T cells with effector function. (a) Scheme
describing the workflow for RNA-seq data preprocessing and filtering. (b) Principal component analysis (PCA) based on present and variable genes.
(c) Heat map showing the z-transformed expression values of present and variable genes, coloured from blue to red. (d) Ratio–ratio plot of log10-
transformed mean ratios of genes that are differentially expressed (fold change (FC) o 2 or 42; FDR-corrected P-value o0.05) comparing CD62Lþ
CX3CR1þ T cells versus naı¨ve T cells (x axis) or CD62L CX3CR1þ T cells versus naı¨ve T cells (y axis). (e) Ratio–ratio plot of log10-transformed mean
ratios of genes being differentially expressed FCo 2 or42; FDR-corrected P-valueo0.05) comparing CD62Lþ CX3CR1 Tcells versus naı¨ve Tcells (x
axis) or CD62L CX3CR1 T cells versus naı¨ve T cells (y axis). (f) Schema describing the workflow for generating the transcriptome core signature for
CX3CR1þ T cells. (g) Heat map of selected genes out of the 363-gene core signature sorted by defined activity groups. Gene expression values were
z-transformed for visualization and are coloured from blue to red. (h) Network visualization of Gene Ontology Enrichment Analysis based on the 363 core
signature genes using BiNGO and EnrichmentMap. Enriched GO terms are depicted by red nodes, where colour and size represent the corresponding
FDR-adjusted enrichment P-value (q-value). Overlap of genes between nodes is indicated by edge thickness.
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understand which biological processes might be linked to the core
signature of CX3CR1þ CD45ROþCD8þ T cells, we performed
Gene Ontology Enrichment Analysis (GOEA) followed by net-
work visualization (Fig. 4h). The major clusters of biological
processes we obtained are compatible with an activated immune
cell including Gene Ontology (GO) terms associated with
immune cell activation, immune response, defense response,
cytolysis, adhesion, response to stress, but also regulation of cell
death and cell death/apoptosis. Taken together, the genome-wide
analysis of gene expression defined a common gene signature that
is shared by human CX3CR1þCD45ROþCD8þ T cells
irrespective of their CD62L expression that have cytotoxic effec-
tor function.
Next, we performed proteome analysis of these T-cell
populations to establish a global protein profile of the CX3CR1þ
memory CD8þ T cells (Supplementary Data 3 and
Supplementary Fig. 5A). Using the identical bioinformatical
approach for data analysis (Fig. 5a), we observed a strong
similarity between CX3CR1þCD62Lhi and CX3CR1þ
CD62LlowCD45ROþCD8þ T-cell populations by principal
component analysis, with CX3CR1neg CD62Llow T cells being
most closely related, whereas CX3CR1negCD62Lhi and naı¨ve
CD8þ T-cell populations were more distinct (Fig. 5b). This was
reflected by hierarchical clustering of variable proteins as both
CX3CR1þCD8þ T-cell populations showed close similarities,
whereas CX3CR1neg CD62Lhi and naı¨ve CD8þ T cells had clearly
different gene expression patterns and CX3CR1neg CD62Llow
T cells revealed a pattern in-between both (Fig. 5c). Visualization
of changes in gene or protein expression by volcano plots
substantiated that separation of memory CD8þ T cells into
CX3CR1þ and CX3CR1neg cells is more powerful than separation
into CD62Lhi and CD62Llow cells to identify genetically distinct
populations (Supplementary Fig. 5B). We next investigated to
which extent candidate molecules from the genome-wide
transcriptome core signature were also present in the proteome.
Similar to previous findings in other cell types, concordance
of expression increased with elevated expression of mRNA
and protein32 (Fig. 5d). Of the 363 genes being part of the
mRNA core signature, 189 were detected by proteome analysis
(Supplementary Data 4). Using only those mRNA core signature
genes and plotting fold-changes between CX3CR1þ and naı¨ve
CD8þ T cells on mRNA and protein levels revealed that the
majority of these cell-type characterizing genes demonstrated
concordant gene regulation (Fig. 5e).
To further validate these findings, we next generated a
proteome-based signature for CX3CR1þ CD8þ T cells following
the approach visualized in Fig. 4a, which resulted in 165 proteins
(Supplementary Data 5). We then used these proteins to annotate
the corresponding mRNA data for plotting fold-changes between
CX3CR1þ and naı¨ve CD8þ T cells on protein and mRNA levels
(Fig. 5f). Again, except for seven genes, we found concordant
gene regulation between proteome and transcriptome suggesting
that post-transcriptional regulation is not highly relevant for
these core signature genes in CX3CR1þ T cells. Next, we
determined the overlap of both approaches to reveal a set of 65
signature genes to be highly upregulated in CX3CR1þ T cells
both on mRNA and protein level (Supplementary Data 6).
Functionally, these genes are best described by GOEA with the
terms immune cell activation, immune response, defense
response, cytolysis, cell adhesion and chemotaxis reminiscent
with an activated immune cell (Fig. 5g). Taken together, this
mathematical modelling of gene and protein expression demon-
strates the value of CX3CR1 as a marker to identify distinct
populations of memory CD8þ T cells that correlate with their
functional properties. Furthermore, we establish a core gene and
protein signature that identifies memory CD8þ T cells with
cytotoxic effector functions. Finally, we identify a close similarity
between CX3CR1-expressing memory T cells irrespective of their
CD62L expression.
CX3CR1þ CD62Lhi CD8þ T cells are a resident effector
memory population in lymph nodes. CX3CR1þCD62LhiCD8þ
memory T cells closely resembled CX3CR1þCD62LlowCD8þ
memory T cells but were clearly distinct from CX3CR1neg
CD62LhiCD8þ memory T cells in functional assays (Fig. 2) and
transcriptome/proteome analyses (Figs 4 and 5). As indicated by
their CD62L expression, we investigated whether CX3CR1þ
CD8þ memory T cells were present in lymph nodes of
CX3CR1þ /GFP reporter mice. Sixty days after viral or bacterial
infection, GFPþ (CX3CR1þ ) CD62LhiCD8þ T cells constituted
about 20–40% of antigen-specific memory CD8þ T cells in
lymph nodes (Fig. 6a,b and Supplementary Fig. 6A). Similarly, we
detected GFPþ (CX3CR1þ ) memory CD8þ T cells in the white
pulp of the spleen (Supplementary Fig. 6B). Although little is
known about the heterogeneity of memory T cells present within
lymph nodes, two distinct positioning and migration patterns
have been described8. Therefore, we investigated whether
CX3CR1þ and CX3CR1neg CD8þ memory T cells differed in
their positioning within the lymph node. Confirming our
previous results8, we found that CD8þ memory T cells were
not located in the deep paracortex as naı¨ve T cells, but instead
were found at the peripheral paracortex and the subcapsular sinus
area. This differential positioning of memory versus naı¨ve CD8þ
T cells was even further pronounced for CX3CR1þ memory
CD8þ T cells (Fig. 6c,d). CX3CR1þCD8þ memory T cells had a
lower velocity and scanned their environment more slowly than
CX3CR1neg CD8þ memory T cells, as analysed by intravital two-
photon microscopy (Fig. 6e and Supplementary Movie 1). We did
not observe CX3CR1þCD8þ memory T cells exiting the lymph
node, which prompted us to investigate the transit time of
memory T-cell populations in the lymph node. We therefore
blocked T-cell entry into lymph nodes by anti-CD62L-antibody
application (Supplementary Fig. 6B,C). As a result, the numbers
of naı¨ve CD8þ T cells and to a lesser extent of GFPneg
(CX3CR1neg) memory CD8þ T cells declined in lymph nodes
(Fig. 6f,g and Supplementary Fig. 6C,D). The numbers of GFPþ
(CX3CR1þ ) memory CD8þ T cells, however, remained
unaltered over a period of 6 days (Fig. 6f,g and Supplementary
Fig. 6B,C). Taken together, CX3CR1þ memory CD62LhiCD8þ
T cells represent a so far unrecognized lymph node-resident
T-cell population positioned in vicinity of CD169þ macrophages
at the subcapsular sinus in anticipation of pathogens that
invade via the lymphatic system. Having established CX3CR1
as a marker that identifies memory CD8þ T cells with
cytotoxic function across tissues, we next aimed to analyse the
abundance of such cells in the context of resolved and chronic
viral infections.
Infection control correlates with CX3CR1þCD8þ T-cells. We
investigated the frequencies of virus-specific CX3CR1þCD8þ T
cells in patients suffering from chronic viral infection, such as
chronic Hepatitis B and chronic Hepatitis C. As expected, we
could only rarely detect virus-specific CX3CR1þCD8þ T cells in
the blood of these patients (Fig. 7a), in contrast to cytomegalo-
virus (CMV)-specific CD8þ T cells from the same donors
(Fig. 7a). In some but not all chronic Hepatitis C patients, we
found few hepatitis C virus (HCV)-specific CD8þ T cells that
expressed CX3CR1 and also co-expressed GzmB as well as per-
forin (Fig. 7b,c and Supplementary Fig. 7A), whereas CX3CR1neg
HCV-specific CD8þ T cells did not show GzmB or perforin
expression (Fig. 7b,c). We did not detect GzmB or perforin
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Figure 5 | Proteome signature of human CX3CR1
þ memory CD8þ T cells with effector function. (a) Scheme describing the workflow for analysis of
proteome data. (b) Principal component analysis (PCA) based on present and variable proteins. (c) Heat map showing the z-transformed expression values of
present and variable proteins, coloured from blue to red. (d) Histogram of normalized RNA-seq expression values of present genes subdivided according to the
corresponding log2-transformed protein expression. Violet bars illustrate expression values and amounts of all present transcripts, whereas green-shaded bars
represent expression values and amounts of transcripts matched to proteins. (e) Fold change rank plot of RNA-seq signature genes (red) with overlay of ranks of
the corresponding proteins (black). Proteins having a log2-fold change lower than 0 are marked in blue. (f) Fold change rank plot of protein signature genes (red)
with overlay of ranks of the corresponding RNA-seq genes (black). Genes having a log2-fold change lower than 0 are marked in blue. (g) Network visualization of
Gene Ontology Enrichment Analysis using BiNGO and EnrichmentMap based on the 65 genes overlapping between the transcriptome and proteome signatures.
Enriched GO terms are depicted by red nodes, where colour and size represent the corresponding FDR-adjusted enrichment P-value (q-value)o0.025.
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Figure 6 | CX3CR1 identifies a distinct population of CD8
þ memory T cells in lymph nodes. (a) Quantification of GFPþ and GFPneg memory
OT-ICX3CR1-GFP T cells within lymph nodes 445 d.p.i. with AdOVA (n¼ 7) or L.m.-OVA (n¼ 3). (b) Representative flow cytometric analysis of GFP and
CD62L expression in memory OT-ICX3CR1-GFP Tcells isolated from lymph nodes. (c) Confocal immunofluorescence images of popliteal lymph nodes from a
mouse harbouring CX3CR1
neg and CX3CR1
þ memory OT-ICX3CR1-GFP T cells. Scale bar, 200mm; zoom 100 mm). (d) Relative distance of CX3CR1neg and
CX3CR1
þ memory CD8þ T cells from CD169þ MF within popliteal lymph nodes. ***Po0.001, t-test. (e) Track length and average speed comparing
CX3CR1
neg and CX3CR1
þ memory CD8þ T cells in the steady state in the interfollicular area over 1 h. ***Po0.001, t-test. (f,g) At 60 days after adoptive
transfer of naı¨ve CD45.1þ OT-ICX3CR1-GFP T cells (1 103) and AdOVA infection, mice were injected daily with anti-CD62L neutralizing antibody
(100mg per mouse i.p.) or PBS over a period of 6 days (n¼ 3 per group). (f) Quantification of total numbers of endogenous naive CD44lowCD8þ
T cells, GFPnegCD44þ memory OT-ICX3CR1-GFP T cells and GFPþCD44þ memory OT-ICX3CR1-GFP T cells in inguinal lymph nodes. *Po0.05, ***Po0.001
t-test. (g) Confocal immunofluorescence images of popliteal lymph nodes at 6 day after anti-CD62L antibody treatment. Scale bar, 200mm. Data from one
of at least two independent experiments are shown.
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expression in hepatitis B virus (HBV)-specific CD8 T cells in the
blood of patients chronically infected with HBV (Fig. 7b). In
contrast, we found many CMV-specific CD8þ T cells from the
same donors who co-expressed CX3CR1þ and GzmB and per-
forin (Fig. 7b,d). These results corroborated our findings that
CX3CR1þ T cells have cytotoxic function and directly control
viral infections. Of note, PD1 was similarly expressed in
CX3CR1þ and CX3CR1neg virus-specific CD8þ T cells in
chronically infected patients (Fig. 7e), indicating that CX3CR1
might more accurately reflect T-cell functionality than PD1
expression. These analyses revealed that virus-specific CX3CR1þ
GzmBþ CD8þ T cells are found in controlled CMV infection
and at low abundance during chronic viral infection in humans.
We next studied CX3CR1 expression on virus-specific CD8þ
T cells during experimental infection with different LCMV clones
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Figure 7 | Presence of CX3CR1
þ CD8þ T cells during acute resolved and chronic viral infection in man and mouse. (a–e) CD8þ T cells isolated from
the blood of human patients chronically infected with HBV or chronically infected with HCV were analysed for virus-specific CD8þ T cells identified by
tetramer staining. CMV-specific CD8þ Tcells from the same patients served as control. (a) Frequency of virus-specific CX3CR1þ CD8þ Tcells. *Po0.05,
**Po0.01, t-test. (b) Flow cytometric analysis of intracellular GzmB expression in CX3CR1þ and CX3CR1neg virus-specific CD8þ Tcells. **Po0.01, t-test.
(c,d) Representative fluorescence-activated cell sorting (FACS) plots showing intracellular GzmB and perforin (Prf1) expression in (c) HCV-specific CD8þ
Tcells and (d) CMV-specific CD8þ Tcells. (e) Flow cytometric analysis of PD-1 expression in CX3CR1þ and CX3CR1neg virus-specific CD8þ Tcells. (f–h)
Analysis of LCMV gp33-specific CD8þ Tcells from CX3CR1þ /GFP mice 40 days after acute LCMV infection (WE strain; n¼ 6) or chronic LCMV infection
(Clone 13 strain, n¼ 7). (f) Quantification of total gp33-specific CD8þ Tcells in the liver and spleen. **Po0.01, t-test. (g) Frequency of GFPþ (CX3CR1þ )
and GFPneg (CX3CR1
neg) cells among gp33-specific CD8þ T cells. *Po0.05, **Po0.01, t-test. (h) Frequency of splenic GFPþ (CX3CR1þ ) and GFPneg
(CX3CR1
neg) gp33-specific CD8þ T cells in response to anti-IL10R antibody treatment. *Po0.05, ***Po0.001, ANOVA. a,b,e show data for at least five
individual patients in each group, c,d show representative FACS plots for individual patients. Data in f–h is pooled from two to three independent
experiments, error bars depict s.e.m.
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or develops into chronic infection (LCMV clone 13;
Supplementary Fig. 7D). At 40 d.p.i., we detected significantly
more LCMV-gp33-specific CD8þ T cells in WE-infected
compared with Clone 13-infected CX3CR1þ /GFP reporter mice
in both the spleen and the liver (Fig. 7f). Among those, the
frequency of GFPþ (CX3CR1þ ) CD8þ T cells was significantly
increased in mice that successfully cleared acute LCMV WE
infection compared with clone 13-infected mice (Fig. 7g). In
chronically infected mice, GFPneg (CX3CR1neg) CD8þ T cells
were abundant among LCMV-specific T cells at 40 d.p.i. (Fig. 7g).
Next, we analysed whether successful therapeutic intervention
would correlate with re-emergence of cytotoxic CX3CR1þCD8þ
T cells. To this end, we treated LCMV Clone13-infected mice
with anti-IL-10 receptor antibodies. In line with published
data33,34, this treatment led to a two-log reduction in viral load
(Supplementary Fig. 7E) and to an increase in the total numbers
of LCMV-specific CD8þ T cells (Supplementary Fig. 7F). This
increase in LCMV-specific CD8þ T cells was followed by an
augmented frequency of GFPþ (CX3CR1þ ) LCMV-specific
CD8þ T cells (Fig. 7h). Together, these results indicate that
virus-specific CX3CR1þ memory T cells are also present during
chronic viral infections albeit at much lower numbers than in
resolved infection and that their numbers increase during
successful therapeutic intervention.
Discussion
Discrete memory T-cell populations with complementary
functions, executed in distinct anatomic locations, cooperate to
mediate immune protection from repeated infection with
intracellular pathogens. Lymphoid tissue homing receptors such
as CD62L and CCR7 have been employed to distinguish between
CD62LhiCCR7þ TCM that home to lymphoid tissues where they
proliferate upon re-challenge and CD62LlowCCR7neg TEM that
remain in the circulation and peripheral tissues where they
mount immediate cytotoxic effector function5. We identify
CX3CR1 as the marker that differentiates memory CD8þ
T cells with direct cytotoxic effector function generated in
response to viral or bacterial infections. CX3CR1 expression
allows their discrimination from memory T cells with
proliferative potential. Using CX3CR1 together with CD62L as
markers, it is possible to stratify memory CD8þ T cells in man
and mouse into four populations. Genome-wide transcriptome
and in-depth proteome analyses provided independent evidence
that CX3CR1 separates functionally distinct memory CD8þ
T-cell populations and allowed us to establish for the first time
a core gene and protein signature of memory CD8þ T cells with
cytotoxic effector function. Based on these results, we identify a so
far unrecognized memory CX3CR1þCD62Lhi CD8þ T-cell
population with cytotoxic effector function that localizes to the
subcapsular sinus of lymph nodes.
Human and mouse CX3CR1þ CD8þ T cells co-expressed
cytotoxic effector molecules (GzmB and perforin) and showed
potent cytotoxicity but had no proliferative capacity. Expression
of CX3CR1 on virus-specific CD8þ T cells appeared shortly after
clearance of experimental infection, then steadily increased to
reach a plateau 2 weeks and was still found up to 200 days after
infection. This suggests that early effector T cells, which are
generated during the initial phases of the pathogen-specific
immune response35, do not express CX3CR1. However, CX3CR1
is expressed shortly thereafter, presumably on both effector
T cells and early memory T cells.
After clearance of infection, only long-lived memory CD8þ
T cells with immediate cytotoxic effector function expressed
CX3CR1. Some but not all CX3CR1þ memory T cells also
showed expression of KLRG1, consistent with the reported
expression of KRLG1 on some memory T cells6.
CX3CR1þCD8þ T cells found 60 days after infection showed
a heterogeneous expression pattern of CD127, indicating that
these cells may not exclusively depend on homeostatic survival
signals delivered through the IL-7 receptor27. Instead CX3CR1
itself may promote survival of memory CD8þ T cells, similar to
the dependence of survival myeloid cells on CX3CR1
expression36. Expression of CX3CR1 has been reported
previously for myeloid cells, such as monocytes, macrophages
and microglia37,38, but also for CD4þ helper T cells that cause
persistent airway inflammation17 and for terminally differentiated
effector CD8þ T cells20,39. Furthermore, CX3CR1 is important
for leukocyte migration and adhesion40 and recruitment of
cytotoxic T cells to sites of inflammation is achieved through
CX3CL1-expressing cells20,39. We did not find evidence for
changes in the functional phenotype of CX3CR1-deficient
memory CD8þ T cells, indicating that CX3CR1-mediated
signals are not the cause of direct cytotoxic effector functions in
memory T cells.
Notwithstanding, CX3CR1 expression accurately distinguished
human and mouse memory T cells with direct cytotoxic
effector functions from those with proliferative potential.
Together with CD62L expression levels, four CD45ROþ CD8þ
T-cell populations can be separated: CX3CR1neg CD62LhiCD8þ ,
CX3CR1negCD62Llow, CX3CR1þCD62Lhi and CX3CR1þ
CD62Llow CD8þ T cells. Transcriptome and proteome analysis
of these cell populations revealed that CX3CR1 was superior to
CD62L to classify distinct memory CD8þ T-cell populations
based on functional properties. This allowed us to establish a core
signature shared by memory CD8þ T cells with cytotoxic
function independent of their tissue localization. This core
signature consists of 363 genes and contains granzymes, perforin,
FASL and IFN-g. The list further entails genes coding for
transcription factors associated with effector function such as
Tbx21, Batf, Nfat, Runx3 (refs 41–43) and surface molecules
found on NK cells such as CD57 (B3GAT1), CD160, killer cell
lectin receptors and NKG7 (ref. 44) or signalling molecules such
as SLAM genes that participate in NK cell function and T -ell
differentiation45. Many of the core signature genes are also
present in the proteome. Some proteins in the core signature,
however, are not found in the gene signature such as s100
proteins, which exert alarm functions upon further oxidative
modifications46. Although expression of these molecules known
to be related to cytotoxic effector functions confirms the
CX3CR1-based core signature, this list will help to refine
human immune monitoring to guide immune therapies and
initiate research into molecular pathways not yet associated with
cytotoxic memory T-cell function.
CX3CR1 expression was found on CD62Llow as well as
CD62Lhi memory CD8þ T cells and transcriptome and
proteome profiles of these two cell populations were almost
identical. Based on these analyses both CX3CR1þCD62low T cells
and CX3CR1þCD62hi memory T cells are best described as
memory T cells with effector function. High CD62L expression
suggested that some CX3CR1þmemory T cells with effector
function could localize to lymph nodes. Indeed, CX3CR1þ
memory CD8þ T cells were found in lymph nodes more than
60 days after viral and bacterial infection. These CX3CR1þCD8þ
T cells localized to the subcapsular sinus and showed prolonged
and continuous interactions with CD169þ macrophages, thus
taking a strategic position where pathogens entering lymphoid
tissues via afferent lymphatics are in first contact with immune
cells8. It is possible that CX3CR1þ CD8þ T cells in the lymph
node may contribute to pathogen-specific immunity through
immediate production of IFN-g, that is required for rapid
initiation of immune responses8,47, after recognizing subcapsular
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macrophages (cross)presenting microbial antigens. Such rapid
induction of IFN-g may initiate CXCL9-mediated recruitment of
CXCR3-expressing memory T cells with proliferative potential48
thereby causing timely induction of T-cell expansion upon local
pathogen encounter in lymph nodes. They may further help to
contain pathogens within this anatomic compartment through
killing of infected macrophages8. CX3CR1þCD62Lhi CD8þ
T cells may therefore complement innate lymphoid cells to
rapidly mount immune responses in the lymph node8. Of note,
CX3CR1þ CD8þ T-cell numbers in lymph nodes did not decline
despite blockade of lymphocyte re-entry with function-blocking
CD62L antibodies, which suggested that these cells remained in
lymph nodes for long periods of time. Alternatively, CX3CR1þ
CD8þ T cells might be superior to CX3CR1neg CD8þ T cells in
their ability to enter lymph nodes via alternative, CD62L-
independent routes. The mechanisms determining positioning
and retention of CX3CR1þ CD8þ T cells in lymph nodes and
the role of CX3CR1þ CD8þ T cells in lymphoid tissues for
induction of pathogen-specific immunity might be assisted by the
CX3C chemokine interface39 but require further investigation.
Another memory T-cell population (TRM) with effector
function is resident in epithelial tissues like the skin, gut and
lung after local infection49–51. TRM develops locally through
signalling by IL-15 and transforming growth factor-b from
KLRG1neg T cells and are identified by expression of CD103 and
CD69 (ref. 52). Both markers are absent from the core signature
for memory CD8þ T cells with direct cytotoxic function.
Furthermore, the core signature of TRM52 is distinct from the
core signature of CX3CR1þ CD8þ T cells. This suggests that
TRM and CX3CR1þ memory CD8þ T cells with cytotoxic
effector function develop via separate pathways, which is
supported by the expression in CX3CR1þ CD8þ T cells of
SMAD7 that regulates transforming growth factor-b-induced
signalling53. Our finding of CX3CR1negCD62LlowCD8þ T cells,
however, as memory T cells with proliferative potential that do
not recirculate to lymphoid tissues and lack KLRG1 expression,
may indicate that these cells are a source for TRM in epithelial
tissues. As CX3CR1negCD62Lhi memory CD8þ T cells in
lymphoid tissue give rise to CX3CR1þ T cells with cytotoxic
function, it is possible that CX3CR1negCD62LlowCD8þ T cells in
response to local cues in epithelial tissues give rise to TRM, which
provide local tissue protection independently from cytotoxicity by
IFN-g-mediated induction of anti-bacterial and anti-viral genes54.
Chronic viral infection develops because of the immune
system’s inability to eliminate or control acute viral infection.
Among the many factors contributing to such failure
of immunity, deletion of virus-specific T cells and development
of dysfunctional T cells with high expression of co-inhibitory
receptors, such as PD1, TIM3 or CTLA4, leading to a
dysregulated pattern of gene expression55, are believed to be
key for chronicity of viral infection56–59. In patients with chronic
HCV infection, we found low numbers of circulating virus-
specific CX3CR1þCD8þ T cells that co-expressed GzmB and
perforin. Only few virus-specific CX3CR1þCD8þ T cells, which
lacked GzmB expression, were detected in patients with chronic
HBV infection, whereas high numbers of GzmB-expressing
CX3CR1þCD8þ T cells were found in CMV-specific CD8þ
T cells. PD1 expression was similar on both, CX3CR1þ and
CX3CR1neg virus-specific CD8þ T cells, indicating that CX3CR1
expression may help to differentiate between PD1 as marker for
recently activated T cells or as marker for dysfunctional T cells.
Experimental LCMV infection studies in mice revealed a high
ratio of virus-specific CX3CR1þ to CX3CR1neg CD8þ T cells in
resolved infection, whereas an inverted ratio was observed during
chronic LCMV infection. It remains to be determined whether
conversion from CX3CR1þ to CX3CR1neg CD8þ T cells can
occur and causes the observed decrease in CX3CR1þCD8þ
T cells in chronic infection. In contrast to the almost identical
transcriptome and proteome profiles of CD62Lhi/lowCX3CR1þ
CD8þ T cells, the profiles of CX3CR1negCD62Llow CD8þ T cells
and CX3CR1negCD62Lhi CD8þ T cells were distinct. It is
possible that CX3CR1negCD62LlowCD8þ T cells comprise a
heterogeneous population of cells that contain T cells with
proliferative potential that do not relocate to lymphoid tissues but
also T cells that were previously CX3CR1þ . Blockade of IL-10
signalling, which is known to strengthen anti-viral immunity
during chronic infection34, re-invigorated numbers of
virus-specific CX3CR1þCD8þ T cells and consequently lead to
a two-log reduction in viral load, suggesting that
CX3CR1þCD8þ T cells might be sensitive to IL-10-mediated
regulation in vivo.
Taken together, the use of CX3CR1 as marker for identification
of memory CD8þ T cells with cytotoxic function will help to
further our understanding of the principles of T-cell memory and
immune protection. Detection of virus-specific CX3CR1þ
GzmBþCD8þ T cells in patients with chronic viral infections
suggests ongoing yet attenuated anti-viral immunity4.
Identification of memory CD8þ T cells with immediate
cytotoxic function through the core signature defined here will
foster the establishment of refined immune monitoring that will
allow for improved guidance of immune therapies.
Methods
Mice. C57BL/6, CD90.1þ C57BL/6, CX3CR1þ /GFP (obtained from the Jung Lab),
OT-ICX3CR1-GFP (CX3CRþ /GFP x T-cell receptor transgenic OT-I), tdTomato
OT-ICX3CR1-GFP and CD45.1þ OT-ICX3CR1-GFP mice were bred under specific
pathogen-free conditions in the central animal facility of the University Hospital
Bonn. Mice were kept under specific pathogen-free conditions and in vivo
experiments were approved by the Local Animal Care Commission of Northrhein
Westphalia. Experiments were conducted with sex-matched female or male mice,
aged 8–12 weeks at the start of each experiment.
Generation and analysis of murine memory CD8þ T cells. To generate
OT-I-derived memory T cells, low numbers (5 102 cells) of FACSorted naive
CD44low GFPneg CD45.1þ OT-ICX3CR1-GFP T cells were adoptively transferred
into sex-matched CD45.2þ recipient mice. Four hours later, mice were either
infected with 5 103 colony-forming units L.m.-OVA by i.p. injection or infected
with 5 106 plaque-forming units (PFUs) AdOVA. Memory OT-I cells were
identified by the expression of the congenic marker CD45.1 in conjunction with a
CD8þCD44þCD127þ phenotype. TCM (CD62Lhi) and TEM (CD62Llow) were
distinguished by CD62L expression. For functional analysis or adoptive transfer
experiments, CD8þ T cells were isolated from the spleen by enrichment with
autoMACS (untouched CD8þ T cell isolation kit, Miltenyi) followed by sorting for
the respective markers on a BD Aria III. Experiments were performed with
CD44þCD127þ memory CD8þ T cells taken from the spleen at 45–70 d.p.i. if
not indicated otherwise.
Infection models and in vivo bioluminescence imaging. Listeria infection. Mice
were infected i.p. with Listeria monocytogenes-expressing OVA (L.m.- OVA)
acquired from log phase of growth in BHI medium. 5 103 colony-forming units
were used to generate memory T cells.
Adenovirus infection. Recombinant adenovirus expressing either OVA
(AdOVA), GFP (AdGFP) or OVA and luciferase as fusion protein (AdOVALUC)
were produced in 293 cells and purified by Cs-chlorid gradient ultracentrifugation
as described previously21. Mice were infected with 5 106 PFU AdOVA by
intravenous injection (i.v.) for generation of memory T cells. 1 107 PFU of
AdOVA or AdGFP were used in re-challenge experiments to assess GzmB
upregulation by memory T cells. Measurement of bioluminescence in livers of
C57BL/6 mice was performed as described previously21. In brief, in vivo
bioluminescence was analysed after intravenous infection with 1 107 PFU
AdOVALUC using an IVIS 200 system (Caliper LifeSciences) 5min after i.p.
injection of Luciferin (50mM in PBS, Caliper LifeSciences). Data analysis was
performed with Living Image 2.50.1 software (Caliper LifeSciences).
LCMV infection. To generate gp-33-specific memory T cells, CX3CR1þ /GFP
mice were infected intravenously (i.v.) with 2 104 PFU of lymphocytic
choriomeningitis virus WE-strain (LCMV WE). Mice were infected intravenously
with 2 106 PFU of LCMV Clone13 or with 2 104 PFU of LCMV WE. Titres of
virus were determined by plaque assay on Vero cells.
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Isolation of human CD8þ T cells. Peripheral blood mononuclear cells (PBMCs)
were obtained from patients chronically infected with HBV, HCV, and healthy
donors visiting the outpatient clinic of the University Hospital Freiburg. All donors
gave written informed consent according to the local ethic committee’s of the
University hospital Freiburg ruling, federal laws and the Declaration of Helsinki.
PBMCs were isolated using density-gradient centrifugation (Pancoll; PAN Biotech,
Aidenbach, Germany).
For some experiments, CD8þ T cells were isolated by autoMACS separation
(Miltenyi) using anti-human CD8 Microbeads (Miltenyi). Virus-specific CD8þ
T cells were analysed using the following APC-labelled MHC class I-tetrameric
complexes: HLA-A*02/HBV core18–27 (FLPSDFFPSV), HLA-A*02/HBV
pol455–463 (GLSRYVARL), HLA-A*02/HCV NS31073–1081 (CINGVCWTV),
HLA-A*02/HCV NS31406-1415 (KLVALGINAV), HLA-A*02/HCV NS5B2594–
2602 (ALYDVVTKL), HLA-B*27/HCV NS5B2841–2849 (ARMILMTHF),
HLA-A*02/CMV pp65495-503 (NLVPMVATV). PBMCs were stained with
tetramer for 15min at 37 C and blocked with murine IgG1 before further staining
for surface markers or intracellular cytotoxic proteins.
Analysis of memory T-cell functions and regulation of T-cell function in vivo.
To analyse cytokine production, restimulation of FACSorted memory T cells was
performed with phorbol myristate acetate (PMA) (5 ngml 1; Sigma-Aldrich) and
Ionomycin (200 ngml 1, Sigma) for 4.5 h in the presence of Brefeldin A and
Monensin (eBioscience). Restimulation of murine memory T cells from
CX3CR1þ /GFP mice (CD90.2þ ) was performed in co-culture with CD90.1 sple-
nocytes as feeder cells. Determination of antigen-specific cytotoxicity against
peptide-loaded target cells was determined in vitro as described60. Analysis of
intracellular GzmB expression was performed directly after isolation of memory
T cells ex vivo without further stimulation.
Blockade of memory T-cell recirculation in vivo. To block access of circulating
CD62Lþ memory T cells to lymph nodes, mice were injected with 100mg of anti-
CD62L antibody (clone MEL14) or PBS as control i.p. over a period of 6 days
before analysis.
In vivo IL-10R blockade during chronic LCMV infection. Mice received i.p. five
times 250mg per mouse of IL-10R-specific antibody (clone 1B1.3a; Bio X Cell) or
rat IgG isotype control antibody (clone KM1.GL113 Bio X Cell) each third day
beginning at 25 d.p.i.
Flow cytometry and fluorescence-activated cell sorting. Flow cytometric ana-
lyses and assessment of mean fluorescence intensity were conducted with a LSR
Fortessa (BD Biosciences). Data were analysed using FlowJo software (Tree Star).
LIVE/DEAD Fixable Stain kit (Invitrogen) was used to exclude dead cells in all
experiments with murine cells, anti-CD16/32 antibody (2.4G2) was used to block
unspecific antibody binding via Fc receptors. Human cells were stained in PBS. The
following antibodies (purchased from BioLegend or eBioscience) were used for
murine samples: CD3 (17A2, dilution 1:200), CD8a (clone 53-6.7, 1:200), CD44
(IM7, 1:300), CD45.1 (A20, 1:200), CD62L (MEL-14, 1:300), CD90.1 (HIS51),
1:400, CD90.2 (HIS51, 1:400), CD127 (ebioSB/199, 1:200), IL-2 (JES6-5H4, 1:200)
and IFN-g (XMG1.2, 1:200). The following antibodies were used for human
samples: CD3 (HIT3a, 1:50), CD8 (RPA-T8, 1:10), CD45RA (HI100, 1:25),
CD45RO (UCHL1, 1:50), CD62L (DREG-56, 1:50), PD-1 (EH12.2H7, 1:25),
CX3CR1 (2A9-1, 1:25), CCR7 (4B12, 1:25) and Perforin (dG9, 1:50). For intra-
cellular staining of cytokines, cells were fixed in 4% PFA and intracellular staining
by anti-IFN-g or anti-IL-2 was performed in Permeabilization Buffer (eBioscience)
for 30min. Staining of Granzyme B (anti-human, cross-reactive with mouse, clone
GB11, 1:100) was performed using the Foxp3/Transcription factor staining buffer
set from eBioscience. All intracellular stainings in murine cells were done in
combination with polyclonal anti-GFP antibody (Life Technologies, Invitrogen;
dilution 1:500). Quantification of cell numbers was done with fluorochrome-
labelled microbeads (CountBright absolute counting beads, Life Technologies,
Invitrogen). Fluorescence-activated cell sorting of splenic naive (CD44lowGFPneg)
or memory (CD44hiCD127þ ) CD8þ T cells was performed with an Aria III cell
sorter (BD). Staining with the corresponding isotype antibody served as control.
Antigen-specific endogenous memory T cells in mice were identified by staining
with fluorochrome-conjugated H-2Kb:SIINFEKL dextramers (AdOVA and L.m.-
OVA infection; Immudex) or H-2Db:KAVYNFATC dextramers (LCMV infection;
Immudex) according to the manufacturer’s protocol.
Immunofluorescence staining. Lymph node and spleens were harvested and fixed
using PLP buffer (0.05M phosphate buffer containing 0.1M L-lysine (pH 7.4),
2mgml 1 NaIO4 and 10mgml 1 paraformaldehyde) for 12 h, then dehydrated
in 30% sucrose before embedding in OCT freezing media (Sakura Finetek). Thirty-
micrometre sections were cut on a CM3050S cryostat (Leica), adhered to Superfrost
Plus slides (VWR), stained, mounted with Fluormount G (Southern Biotech) and
acquired on a 710 confocal microscope (Carl Zeiss Microimaging). Frozen sections
were permeabilized and blocked in 0.1M Tris (AppliChem) containing 0.3% Triton
X-100 (GERBU Biotechnik), 1% FCS (Biochrom AG), 1% GCWFS (Sigma Aldrich)
and 1% normal mouse serum (Life Technologies). Serial lymph node sections were
prepared, each section was visually inspected using epifluorescent light microscopy,
and several representative sections from different lymph node (LN) areas were
acquired using confocal microscopy for detailed analysis. The following antibodies
were used for staining: anti-CD8 (5H10; Invitrogen), anti-CD169 (c3D6.112;
AbDSerotec), ER-TR7 (Santa Cruz Biotechnology), anti-B220 (RA3–6B2; Life
Technologies), anti-F4/80 (BM8; BioLegend), anti-CD45.1 (A20; eBioscience).
Unconjugated primary antibodies were stained with AF-conjugated secondary
antibodies (Life Technologies). For CX3CR1 detection, staining with a secondary
rabbit anti-GFP (Life Technologies) was used to increase the signal. Primary
antibodies were used at a concentration of 1:200, secondary antibodies at a
concentration of 1:1,000.
Intravital two-photon imaging. Mice were anaesthetized with isoflurane (Abbott,
Wiesbaden; 2.5% for induction, 1–1.5% for maintenance, vapourized in an 80:20
mixture of O2 and air), popliteal LNs were exposed and intravital microscopy was
performed using a protocol modified from a previous report61. For imaging of
td-Tomato and GFP (CX3CR1)-transgenic CD8þ T cells, we used a Zeiss 780
microscope equipped with a Chameleon laser (Coherent) tuned to 930 nm and a
 20 water dipping lens (numerical aperture¼ 1.0, Zeiss, Jena). The microscope
was enclosed in an environmental chamber, in which anaesthetized mice were
warmed by heated air, and the surgically exposed lymph node was kept at 36–37 C
with warmed PBS. For dynamic imaging, we recorded a z-stack of 57 mm using
3 mm step size in the interfollicular area and acquired every 40 s. Raw imaging data
were processed and analysed with Imaris software (Bitplane).
Analysis of microarray-based gene expression profiling data. We used a
previously generated data set to identify genes associated with memory T cells
(GSE63118). Genome Studio (Illumina) was used to profile the raw expression
data, where probesets having missing bead types were excluded from the analysis.
Processed data of 23 samples were imported into Partek Genomics Suite (PGS)
software (v6.6; Partek Inc., log2-transformed and normalized using quantile nor-
malization. Using a background log2-intensity of 6.7886, probesets showing a mean
expression lower than this threshold in all five investigated groups were excluded,
resulting in 20,515 defined present genes. Their expression values were standar-
dized to a mean of zero and standard deviation of one, and the genes were clustered
into 25 groups by using 20,000 training iterations to obtain a self-organizing map.
For each condition, the clusters were visualized as heat map based on their
eigenvalues, where increased values are shown in red, decreased values in blue and
intermediate values in green.
RNA isolation and purification for RNA-seq analysis. Total RNA was extracted
with QIAzol Lysis Reagent (Qiagen) and then purified using the miRNeasy Mini
Kit (Qiagen) according to the manufacturers’ recommendations. The RNA integ-
rity (RNA Integrity ScoreZ6.8) and quantity were determined on the Agilent 2100
Bioanalyzer (Agilent) per the manufacturer’s recommendation and subjected to
cDNA synthesis.
cDNA library preparation and RNA sequencing. To generate cDNA libraries,
1,000 pg total RNA were amplified and converted to cDNA using NuGEN’s
Ovation RNA-Seq kit V2. In brief, the mRNA was reverse transcribed to synthesize
the first-strand cDNA by using a combination of random hexamers and a poly-T
chimeric primer. Double-stranded DNA is generated by fragmentation of the
mRNA template strand using RNA-dependent DNA polymerase. The double-
stranded DNA was purified using Agencourt RNAClean XP beads. The DNA is
amplified linearly using a SPIA process in which RNase H degrades RNA in DNA/
RNA heteroduplex at the 50-end of the double-stranded cDNA, after which the
SPIA primer binds to the cDNA and the polymerase starts replication at the 30-end
of the primer by displacement of the existing forward strand. Finally, random
hexamers were used to amplify the second-strand cDNA linearly. Following
amplification, 5.0 mg cDNA was fragmented to B200 bp using the Covaris S2 and
the fragmentation parameters described in the Encore SP Rapid DR Multiplex
library preparation protocol (NuGEN). The remainder of the library preparation
followed the manufacturer’s protocol as described in Encore SP Rapid DR Mul-
tiplex System. Paired-end sequencing of bar-coded cDNA libraries at 101 cycles
(100 bases each end) was carried out on a HiSeq 1000. The raw sequence data have
been deposited to GEO with accession number GSE63147.
Sample preparation for MS analysis. Cell pellets were washed in PBS and lysed
in 6M Guanidinium chloride (GdmCl), 10mM HEPES (pH 8) and 10mM
dithiothreitol. Cells were heated for 10min at 95 C and sonicated for 15min at
4 C (level 5, Bioruptor, Diagenode). Cysteine residues were alkylated in the dark
for 30min with 55mM iodacetamide. Lysates were diluted 1:3 with 50mM
ammoniumbicarbonate for a proteolytic digest with LysC (1:50, w/w, Wako) for
3 h. Samples were further diluted to 0.6M GdmCl and digested with trypsin (1:50,
w/w, Promega) at room temperature overnight. Buffer exchange was performed on
C18 material (Empore, IVA-Analysetechnik). Peptide mixtures were eluted in 80%
acteonitrile (ACN) and the organic solvent was removed by centrifugal evapora-
tion. Cleaned peptides were resuspended in 2% ACN, 0.1% trifluoroacetic acid and
0.5% acetic acid.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9306
14 NATURE COMMUNICATIONS | 6:8306 |DOI: 10.1038/ncomms9306 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
LC-MS/MS. Peptides were separated on an EASY-nLC 1000 HPLC system
(Thermo Fisher Scientific) coupled online to the Q Exactive mass spectrometer via a
nanoelectrospray source (Thermo Fisher Scientific). Peptides were loaded in buffer A
(0.5% formic acid) on in house packed columns (75mm inner diameter, 50 cm length
and 1.9mm C18 particles from Dr Maisch GmbH). Peptides were eluted with a
nonlinear 240min gradient of 5–60% buffer B (80% ACN, 0.5% formic acid) at
a flow rate of 250 nlmin 1 and a column temperature of 50 C. Operational
parameters were real-time monitored by the SprayQC software. The Q Exactive was
operated in a data-dependent acquisition mode with a survey scan range of
300–1,700 m/z and a resolution of 70,000 at m/z 200. Up to the five most abundant
isotope patterns with a charge Z2 were isolated with a 2.2 Thomson (Th) isolation
window and subjected to higher-energy collisional dissociation fragmentation at a
normalized collision energy of 25. Fragmentation spectra were acquired with a
resolution of 17,500 at m/z 200. Dynamic exclusion of sequenced peptides was set to
45 s. Thresholds for ion injection time and ion target values were set to 20ms and
3E6 for the survey scans and 120ms and 1E5 for the MS/MS scans, respectively. Data
were acquired using the Xcalibur software (Thermo Scientific).
MS data analysis. MaxQuant software (version 1.3.10.18) was used to analyse MS
raw files62. MS/MS spectra were searched against the human Uniprot FASTA
database (Version May 2013, 88’847 entries) and a common contaminants
database (247 entries) by the Andromeda search engine. Cysteine
carbamidomethylation was applied as fixed and N-terminal acetylation and
methionine oxidation as variable modification. Enzyme specificity was set to
trypsin with a maximum of two missed cleavages and a minimum peptide length of
seven amino acids. A false discovery rate (FDR) of 1% was applied on peptide and
protein level. Peptide identification was performed with an allowed initial
precursor mass deviation of up to 7 p.p.m. and an allowed fragment mass deviation
of 20 p.p.m. Nonlinear retention time alignment of all measured samples was
performed in MaxQuant. Peptide identifications were matched across different
replicates within a time window of 1min of the aligned retention times. In
addition, single shot runs were match against a T-cell peptide library built from
single shot MS measurements of primary human T cells at various activation
stages. Protein identification required at least 1 razor peptide. A minimum ratio
count of 1 was required for valid quantification events via MaxQuant’s Label Free
Quantification algorithm (MaxLFQ). Data were filtered for common contaminants
and peptides only identified by side modification were excluded from further
analysis. In addition, a minimum of three valid quantifications in at least one group
of biological replicates was required. Remaining missing values were imputed with
random numbers from a normal distribution (mean-shift¼ 1.8; width¼ 0.3), to
simulate low abundance values below the noise level.
Bioinformatics of RNA-seq data. RNA-Seq reads were aligned against the human
reference genome hg19 using TopHat v2.0.11. To obtain transcript and gene
information, the aligned reads were mapped against the hg19 RefSeq database
Release 66 (ref. 63) using Partek Genomics Suite (PGS) software (v6.6; Partek Inc.).
Annotated data were normalized using the DESeq2 package within the statistical
software R version 3.0.2. In addition, normalized read counts lower than 1 were set
equal to 1 to avoid spurious fold changes later on. The genes were filtered to those
being present within the data set, defined as having a mean normalized read count
larger than 10 in at least one of the investigated groups. Of those, the genes being
variable (Po0.05) across the data set were visualized via principal component
analysis and via a heat map based on z-transformed data using PGS. The list of
present genes was then further analysed by three different methods to obtain a core
signature for CX3CR1þ CD8þ T cells. Genes commonly and significantly
upregulated in CD62Lþ CX3CR1þ and CD62L CX3CR1þ T cells were
identified by using an ANOVA model (FC42, FDR-corrected P-valueo0.05).
Ratio/ratio plots were used to compare different cell populations on the single-gene
level. Clusters of co-regulated genes were determined by applying the Markov
Clustering (MCL) algorithm within BioLayout Express3D version 3.2 (ref. 64) with
standard criteria on those genes showing a Pearson correlation of at least 0.85.
Weighted correlation network analysis was performed in R using a power of 7, a
minModuleSize of 30 and a MEDissThres of 0.3 resulting in 20 clusters. For the last
two methods, the one cluster representing genes being highly expressed in
CX3CR1þ and only moderately expressed in CX3CR1 and naı¨ve T cells were
chosen. Each of these clusters was then intersected with the list of significantly
upregulated genes, and the union of the two intersection lists containing 455 genes
was considered as a pre-signature. To refine this signature, genes showing a fold
change lower than 1.5 as well as an absolute expression value difference lower than
50 between CX3CR1þ and CX3CR1 cells were removed. After finally excluding
known polymorph MHCII genes, a signature of 363 genes remained. The
distribution of expression values of those genes was displayed separately for all
five conditions via boxplots. Sixty-five specific genes were visualized in form of a
heat map based on z-transformed data. Finally, all 363 signature genes were linked
to prior knowledge by performing GOEA using the Cytoscape65 plug-in
BiNGO (v2.44) with an FDR threshold of 0.05 to include only significant results.
The Cytoscape plugins Enrichment Map (v1.1) with a Jaccard coefficient of 0.25
and an FDR Q-value cutoff of 0.025 as well as Word Cloud were used to visualize
the GO network.
Bioinformatics of proteome data. Proteins being variable (Po0.05) across the
data set were visualized via principal component analysis and via a heat map based
on z-transformed data using PGS. To link the RNA-seq expression data to the
protein data, the data sets were matched by using the UniProt database. The
distribution of normalized RNA-seq expression values of present genes was
visualized in the form of a histogram splitted into different protein expression
classes. To obtain a core signature for CX3CR1þ CD8þ T cells based on protein
data, the same approach as used for the RNA-seq data was applied, harbouring
only a few changes in terms of the used parameters. The MCL algorithm in
BioLayout Express3D was applied on proteins showing a Pearson correlation of at
least 0.8. For weighted correlation network analysis, a power of 18 and a MED-
issThres of 0.5 were used. Collating the intersections of each CX3CR1þ cell
representing cluster with the significantly and commonly upregulated proteins
resulted in a pre-signature of 192 proteins. After excluding proteins encoded by
known polymorph MHCII genes as wells as those proteins having an absolute
expression difference of o1eþ 06 between CX3CR1þ and CX3CR1 cells, a
refined signature of 165 proteins remained. Fold change rank plots were used to
map their change of expression to their corresponding change in the RNA-seq
data set, as well as the same vice versa for the defined RNA-seq signature.
Overlapping the transcriptome and proteome signatures resulted in 65
CX3CR1þ -associated proteins, which generated a clearly refined GO network
based on the same enrichment parameters as used for the transcriptome-based
signature network.
Statistical analysis. The two-tailed Student’s t-test was used for the statistical
analysis of differences between two groups. Comparison of multiple groups was
done using two-way ANOVA.
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